The Applied Pharmaceutical Analysis conference is a part of The Boston Society Applied Pharmaceutical Congress series and is composed of three workshops: Regulated Bioanalysis, Discovery Bioanalysis and New Technologies, and Mechanistic ADME. This conference series was developed to fill the void between academic societies, commercial conferences, and large trade shows, by offering small, focused meetings, organized exclusively by pharmaceutical industry leaders and produced by a non-profit organization.
Charles River is pleased to participate in meeting’s scientific program. Don't miss our presenters and session chairs:
Regulated Bioanalysis Workshop
Session Chair, Jakal Amin, MSPH will lead Session II on the Digital State of Regulated Bioanalysis
Monday, September 9, 8:50 a.m. – 10:25 a.m. EST
Session Chair Jennifer Vija, PhD will lead Session IV on Interpretation and Implementation of Recently Issued Bioanalytical Guidance Documents
Tuesday, September 10, 8:55 a.m. – 10:30 a.m. EST
Jennifer Vija, PhD
Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners
Tuesday, September 10, 9:30 a.m. – 10:00 a.m.
Mechanistic ADME Workshop
Sanne Demandt, PhD,
Advances and Challenges for T Cell Therapies
September 10, 11:55 a.m. – 12:25 p.m. EST
Session Chair, Elizabeth Groeber, PhD, MBA will lead Session II on Cell and Gene Therapies (including Bioanalytical role in GT)
Tuesday, September 10, 10:50 a.m. – 12:55 p.m.
Visit us in the exhibit area at table 10 to learn how Charles River can support your development program from early discovery through to the clinic with expert ADME/DMPK and bioanalytical services that expedite your time to market.
Want to set aside dedicated time to talk with our scientists? Request a meeting by emailing us at [email protected].